Alpensial (Herbal Sleep Blend)

Alpensial is a proprietary herbal sleep blend combining Valerian, Chamomile, Hops, Skullcap, and Passionflower, whose key bioactives — valerenic acid, apigenin, and linarin — modulate GABA-A receptors and serotonin pathways to promote relaxation and sleep onset. Evidence supporting the blend is derived from individual component studies rather than trials on this specific formulation.

Origin & History

Alpensial is a proprietary herbal sleep support blend typically comprising extracts from plants including Valerian root (Europe/Asia), Chamomile flowers, Hops flowers, St. John's Wort, California Poppy, and Holy Basil leaf. It is processed via alcohol-free liquid extraction (glycerite) or powder/capsule forms using crude extraction at a 1:3 dry plant-to-solvent ratio, without GMO, gluten, or additives.

Historical & Cultural Context

Individual herbs have historical uses in European and Native American traditions: Valerian for sleep since ancient Greece/Rome, Chamomile and Hops in European folk medicine for relaxation (centuries-long), California Poppy by Native Americans for calm, and Holy Basil in Ayurveda for stress. No specific traditional context exists for the Alpensial blend itself.

Health Benefits

• May support relaxation through valerenic acid from Valerian and apigenin from Chamomile (evidence: individual component studies only)
• Potentially promotes calmness via flavonoids and linarin from Hops, Skullcap, and Passionflower (evidence: product claims, no blend-specific trials)
• May help with sleep onset through GABA receptor modulation (evidence: theoretical based on component herbs)
• Could support stress response through honokiol/magnolol from Magnolia (evidence: vendor descriptions only)
• Possible nervous system calming effects (evidence: traditional use of individual herbs, no clinical data for blend)

How It Works

Valerenic acid from Valerian root inhibits GABA transaminase and acts as a positive allosteric modulator at GABA-A receptors, reducing neuronal excitability and promoting sedation. Apigenin from Chamomile binds to benzodiazepine-sensitive GABA-A receptor sites, exerting anxiolytic effects without significant sedative tolerance. Linarin and isovitexin from Hops and Passionflower further potentiate GABAergic tone while Passionflower's chrysin may modestly interact with 5-HT2A serotonin receptors, collectively supporting the transition to sleep.

Scientific Research

No human clinical trials, RCTs, meta-analyses, or PubMed PMIDs specifically evaluate Alpensial or an identical branded blend. Evidence is limited to individual component studies mentioned in product claims, such as valerenic acid from Valerian or apigenin from Chamomile supporting calmness, but without blend-specific trial data on design, sample size, or outcomes.

Clinical Summary

Individual components of Alpensial have been studied independently; Valerian extract (300–600 mg) showed modest improvements in sleep latency and quality in randomized trials involving 100–900 participants, though effect sizes were small and heterogeneity was high. Chamomile extract (270–540 mg) demonstrated reduced generalized anxiety and improved sleep quality scores in a 28-day RCT of 34 postpartum women. Passionflower tea and extract improved subjective sleep quality in a small crossover RCT of 41 adults. No published clinical trial has evaluated the Alpensial blend as a combined formulation, meaning efficacy claims rest entirely on component-level evidence and cannot be directly extrapolated.

Nutritional Profile

Alpensial is a multi-herb sleep blend with negligible macronutrient content (effectively 0g fat, protein, and carbohydrates at typical serving doses of 300–600mg total blend). Primary bioactive compounds include: Valerian root extract contributing valerenic acid (approximately 0.8–1.0% of extract weight, ~2–5mg per serving), isovaleric acid, and iridoids (valepotriates); Chamomile providing apigenin (a flavonoid, estimated 0.5–1.2% of extract, ~1–3mg per serving) and alpha-bisabolol; Hops (Humulus lupulus) supplying 2-methyl-3-buten-2-ol (~0.15% of dried herb), methylbutenol, and bitter acids (humulone, lupulone); Passionflower contributing flavonoids including chrysin (~0.5–1% of extract) and vitexin; Skullcap providing baicalin and scutellarein (flavonoids, ~1–2% of extract). Micronutrient content is negligible at functional doses. Bioavailability notes: apigenin has moderate oral bioavailability (~1–2 hours to peak plasma), valerenic acid undergoes hepatic first-pass metabolism limiting systemic levels, and chrysin has poor standalone bioavailability (~1%) though herbal matrix co-factors may modestly enhance absorption. No significant fiber, vitamin, or mineral contribution at standard serving sizes.

Preparation & Dosage

Liquid glycerite extracts: 30-60 drops (about 1-2 mL) in water or juice, taken 30-45 minutes before bed. Capsule forms lack specific blend dosages, though individual herb standardizations include Valerian (0.8% valerenic acid), Chamomile (1% apigenin), and Holy Basil (2.5% ursolic acid). No clinically studied dosages for Alpensial powder or standardized extracts are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Melatonin, L-Theanine, Magnesium Glycinate, GABA, 5-HTP

Safety & Interactions

Valerian may cause morning grogginess, vivid dreams, and mild GI upset at doses above 600 mg; rare cases of hepatotoxicity have been reported with long-term high-dose use. The blend's GABAergic components can potentiate central nervous system depressants including benzodiazepines, alcohol, and sedative antihistamines, increasing drowsiness and impairment risk. Skullcap (Scutellaria lateriflora) has been associated with liver toxicity when adulterated with Germander; sourcing quality is critical. Alpensial is not recommended during pregnancy or breastfeeding due to insufficient safety data on Valerian and Passionflower in these populations.